Get ready people for a significant re-rating of CXY. The chart is looking good. We will definitely see new highs for CXY.Trial burn expected in March. News coming.DYOR
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%